Clinical Trials Webinars

This webinar aims to enhance understanding of Persistent Pulmonary Hypertension of the Newborn (PPHN), including its underlying physiology, diagnosis, and management, while emphasizing the collaborative efforts between neonatologists, paediatric intensivists and cardiologists to optimize patient care and outcomes. Our neonatologist speaker, Prof. Manuel Sánchez Luna, will discuss the importance of early recognition and therapeutic intervention in managing PPHN and key therapeutic strategies to improve outcomes and prevent mortality in the extremely severe cases. In addition, Prof. Sánchez Luna will address the utilization of non-invasive monitoring techniques, including pre- and post-ductal oxygen saturation, volumetric capnometry, and heart ultrasound, to identify PPHN and monitor response to specific therapies. By joining this session, you will also get insights from our cardiologist speaker, Prof. Maurice Beghetti, on the potential cardiac causes that may mimic PPHN in neonates and the importance of differentiating between cardiac and lung disease-induced pulmonary hypertension for appropriate treatment selection. Prof. Beghetti will also highlight different etiologies of PPHN and emphasize the importance of excluding cardiac lesions responsible for PPHN-like presentation. Target audience of this webinar: ICU Doctors in training – PICU, NICU and CICU; Cardiology doctors in training, ICU nurses, ECMO specialists, and other Allied Health Professionals. *This webinar is supported by an unrestricted educational grant from Masimo.

Join The Journal of Cardiovascular Aging for a webinar featuring Sanjiv Sam Gambhir, M.D., Ph.D. as he lectures on Stem Cell & Genomics: From Precision Medicine to Clinical Trial in Dish Time. The webinar will take place on April 8, 2024, at 9:00 AM (New York time, UTC-4).

The tumor microenvironment is a complex mix of cancer cells, immune cells, and other components that all play a part in tumor progression, metastasis, and therapy responses. Understanding the highly dynamic nature of the tumor microenvironment and the factors that influence those changes is essential for developing effective precision oncology therapies. Innovations in computational pathology and artificial intelligence, coupled with novel multiplex biomarker assays, are critical to fostering that understanding. Together, they are paving the way for scientists to better characterize the unique cancer cell populations, spatial relationships, and differences in immune responses in the tumor microenvironment.In this GEN webinar, Michael Downing, Senior Image Analysis Scientist at Ultivue, will review the state of the field and introduce Ultivue’s two core platform technologies: InSituPlex® assays, and its proprietary Spatial Image Analysis pipeline featuring UltiStacker.AI™ and UltiAnalyzer.AI™. He will also explain how these technologies work together to provide high confidence insights from tumor data for scientists developing precision cancer therapies.Topics covered in the webinar will include:How AI-supported spatial image analysis together with Ultivue’s InSituPlex assays deliver accurate and scalable insights into the biology of the tumor microenvironment.How Ultivue’s 12-plex assay verification demonstrates its readiness to provide a comprehensive view of the tumor microenvironment.A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

In the United States, public health and health care delivery have largely taken different and siloed approaches, with health care focused on the treatment of individuals and public health centered on the total population within a geographic region. Collaboration between the sectors is essential to advancing both health outcomes and equity—a lesson driven home during the COVID-19 pandemic. In a new webinar, Manatt Health will provide an in-depth look at the innovative ways California health agencies are working together to bridge the gap between public health and managed care health care delivery—and what other states can learn from the California model.

As the life sciences industry continues to evolve rapidly, clinical research organizations (CROs) and trial sites are facing new challenges and opportunities in 2024. This webinar is designed to provide industry leaders with a deep dive into the most critical clinical trial supply trends and the strategies needed to navigate these effectively.

A webinar organised by the APM Juniors’ Committee. Date: Tuesday 27 February 2024 Time: 18:00 – 19:30 Speakers: Professor Fliss Murtagh and Dr Donna Wakefield. Learning Objectives: 1) Why bother with research in palliative care, including benefits and challenges 2) Hot topics in palliative care research 3) How to progress from an idea to implementing change, and how to get involved in each level. This event is FREE to attend. Ticket holders will be sent the recording after the session. Please book your place to ensure you are on the mailing list for the joining link and the recording. The joining link will be emailed to you via the email you have registered your place with the day before the event takes place. Please remember to check your Junk Mail folders in case the invite has fallen in there. To avoid our emails falling into junk folders please make sure your IT department ‘safelist’ the following email addresses kate@munrosmith.co.uk | becki@munrosmith.co.uk. It has been noted that some email accounts are viewable in plain text only. With this in mind, we will provide the meeting ID and passcode to your joining instructions to avoid any issues with broken links.

This webinar pertains to fry shortening reduction, and how it impacts the bakery sector's savings. A significant focus will be given to food ingredients and innovations, along with food sustainability and environment.

Staying current with regulatory changes is important when it comes to staying out of trouble with regulatory agencies, maintaining your reputation, and successfully conducting clinical trials. Join Marc Wartenberger, Director Corporate QA & Compliance at CRIO, for a review of new regulations, guidance, and decisions from 2023 that will impact clinical research.

Discover an informative webinar delving into how strategic oncology clinical trial design shapes success in early oncology studies using novel approaches. Trial design in early-phase oncology studies has a critical impact on the success of the study. Novel approaches such as biomarker stratification, adaptive enrichment designs, outcome-adaptive randomization and the integration of real-world data have been developed. In addition, under Project Optimus, dose expansion requires the selection of the most appropriate dose and schedule to be brought into the registrational trial, which also needs to be accomplished via dose-finding studies in early-phase trials. Attendees will learn insights into the trade-offs between protocol design options and offer insight into developing a trial structure that maximizes the chances of success in later phases of research while minimizing risk. Join this webinar to explore the intricate world of oncology trial design and gain valuable insights to enhance research approaches.

Discover an informative webinar discussing digital biomarkers in neuropsychiatric trials, leveraging an artificial intelligence (AI)-driven platform for enhanced treatment outcomes. Drugs for psychiatric conditions suffer some of the lowest approval rates when compared to other major therapeutic areas. Underlying factors can include complex and poorly understood etiology, which are heterogeneous in presentation, and underlying pathophysiology. Additionally, traditional clinical studies fail to objectively assess cognitive function as part of patient eligibility criteria or stratify patients according to the presence or degree of cognitive impairment. Cognitive function assessments and electroencephalogram (EEG) enable the measurement of pharmacodynamic endpoints in early-stage, translational psychiatric studies, however many studies do not leverage these tools today.